MBL obtained manufacturing and marketing approval on September 14, 2022 for its new GLINE-SARS-CoV-2&FluA+B, a simple test kit that simultaneously detects both the SARS-CoV-2 antigen and influenza virus antigen in a single test cassette. Sales will begin on September 30.
This kit detects the SARS-CoV-2 antigen, influenza A virus antigen, and influenza B virus antigen in nasopharyngeal or nasal swab fluid using an immunochromatographic* method.
*Immunochromatography: A method to test for viral infection by dropping a sample into a kit. Since it uses capillary action, no machine is required for the test, and the test can be performed visually. It is a simple and rapid method that can determine the result within 15~20 minutes after specimen is dropped into the reaction cassette.
A single test cassette is used to test for influenza A and B viruses as well as novel coronaviruses.
The ability to perform both tests with a single specimen collection reduces the burden on patients at the time of sample collection, as well as the testing workload for healthcare professionals.
Contact details
-
- Missy Bindseil
-
JSR Life Sciences Company Inquiries
Director, Marketing & Communications - mbindseil@jsr-nahq.com
Related topics
Related news
New Antibody Development for Use in Drug Delivery to Motor Nerves
MBL raised and delivered monoclonal antibodies for Jiksak Bioengineering, a startup company with proprietary technologies developed for new therapeutic innovation in motor neuron degenerative disea...
MBL Obtains Regulatory Approval for SARS-CoV-2 and Influenza Virus Antigen Test OTC Kit
This product detects the SARS-CoV-2 and Influenza virus antigen in nasal swab fluid by the immunochromatography method. MBL can sell this product at pharmacies, drugstores and pharmacy online sites.
MBL Launches an OTC Kit for SARS-CoV-2 Antigen Test
Medical & Biological Laboratories Co., Ltd. successfully acquired regulatory approval on November 11, 2022 for its SARS-CoV-2 antigen test OTC kit “GLINE-2019-nCoV Agキット(一般用).”
Crown Bioscience & MBL Launch Joint Venture to Serve Japanese Biopharmaceutical Community
Crown Bioscience & MBL, a joint venture between two JSR Life Sciences companies formed earlier this year, announce today the launch of their full-service drug discovery and development capabilities...